19.09.2014
- The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...
16.09.2014
- Roche's cancer drug Avastin as a cheaper treatment for wet age-related macular degeneration (wAMD), a leading cause of blindness in the elderly, does not appear to increase deaths...
02.09.2014
- Safety is of paramount importance within the petroleum and chemical industries. The aims of safety systems in processing plants are to prevent damage to equipment, avoid injury to...
25.08.2014
- Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. The...
17.07.2014
- Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...
03.07.2014
- Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...
03.06.2014
- Swiss pharmaceutical producer Roche has announced plans to buy privately held US gene-sequencing firm Genia Technologies for up to $350 million, securing access to a technology...
21.05.2014
- Swiss pharmaceutical producer Roche plans to invest 120 million Swiss francs in new production facilities at Basel. Around €85 million of the total will go for new chemical...
